Michael A. MediciPrincipal
Michael joined Summit Partners in 2005 as an Associate. Today, as a Principal, he focuses primarily on the technology and healthcare & life sciences sectors. His board directorships and investments include Acacia Communications, Accedian Networks, Anesthetix (acquired by TeamHealth), ApoCell, Clarabridge, Diagnostic Hybrids (acquired by Quidel Corporation), Fermentas International (acquired by Thermo Fisher Scientific), Hiperos, Logi Analytics, PeerApp, Telerik and Zenoss.
Prior to Summit, Michael worked for Prudential Capital Group.
Michael received a BS in finance and international business from Georgetown University.